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Environment, Human Reproduction,
Menopause, and Andropause
by Alex Vermeulen
As the hypothalamic gonadotropin-releasing hormone (GnRH) pulse generator is an integrator of hormo-
nal, metabolic, and neural signals, it is not surprising that the function of the hypothalamogonadal axis is
subject to the influence ofa large array ofenvironmental factors. Before puberty, the central nervous system
(CNS) restrains the GnRH pulse generator. Undernutrition, low socioeconomic status, stress, and emotional
deprivation, all delay puberty. During reproductive life, among peripheral factors that effect the reproductive
system, stress plays an important role. Stress, via the release of corticotropin-releasing factor (CRF),
eventually triggered by interleukin 1, inhibits GnRH release, resulting in hypogonadism. Effects ofCRF are
probably mediated by the opioid system. Food restriction and underweight (anorexia nervosa), obesity,
smoking,andalcohol allhavenegativeeffectsontheGnRHpulsegeneratorandgonadalfunction.Ageanddiet
are important determinants offertility in both men and women. The age-associated decrease in fertility in
women has as a major determinant chromosomal abnormalities ofthe oocyte, with uterine factors playing a
subsidiaryrole.Age at menopause, determined byovarian oocytedepletion, is influencedbyoccupation, age at
menarche, parity, age at last pregnancy, altitude, smoking, and use oforal contraceptives. Smoking, however,
appears to be the major determinant. Premature menopause is most frequently attributable to mosaicism for
Tlurner Syndrome, mumps ovaritis, and, above all, total hysterectomy, which has a prevalence ofabout 12-15%
in women 50 years old. Premature ovarian failure with presence of immature follicles is most frequently
caused by autoimmune diseases or is the consequence of irradiation or chemotherapy with alkylating
cytostatics. Plasma estrogens have a physiological role in the prevention ofosteoporosis. Obese women have
osteoporosis less frequently than women who are not overweight. Early menopause, suppression of adrenal
function (corticoids), and thyroid hormone treatment all increase the frequency ofosteoporosis.
Aging in men is accompanied bydecreased Leydigcell and Sertoli cell function, which has apredominantly
primary testicular origin, although changes also occur at the hypothalamopituitary level. Plasma testoster-
one levels, sperm production, and sperm quality decrease, but fertility, although declining, is preserved until
senescence. Stress and disease states accelerate the decline on Leydig cell function. Many occupational
noxious agentshave anegativeeffectonfertility.There isevidenceforadeclineofspermqualityinthegeneral
male population over the last two decades, probably a consequence of increasing pollution, irradiation, and
population stress. If the evidence is confirmed, it might be mandatory to reduce drastically pollution,
irradiation, and other noxious agents that may impair spermatogenesis.
Introduction
The human organism acquires its full reproductive
capacity after completion of puberty, the fertile period
covering about 35 years in women, whereas in men
reproductive capacity, although decreasing with age, per-
sists until a very old age.
Puberty
Puberty represents the final stage of sexual differentia-
tion during which time the individual acquires full repro-
ductive capacity, with not only maturation of sexual organs
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andformation oftheoocytes andmature spermatozoa,but
also development of secondary sex characteristics under
the influence of sex hormones. Puberty is initiated by an
increase inboth frequencyand amplitude ofgonadotropin
pulses, which activate gonadal growth and function. The
increaseingonadotropinpulsesisinitiallyassociatedwith
theonsetofnocturnal,non-REM(rapideyemovement)sleep
(1,2). This pulsatile gonadotropin release by the gonado-
trophs reflects the pulsatile release of gonadotropin-
releasing hormone (GnRH) into the hypophyseal portal
circulation by a group of specific neuroendocrine cells in
the medio-basal hypothalamus called the pulse generator.
ThetriggerofthisactivationoftheGnRHpulsegenerator,
and hence the initiation ofpuberty remains unknown. It
has been suggested that the initiation of puberty might
involve a decreased sensitivity ofthe hypothalamic pulse
generator to the inhibitory effects of opiate peptides (3).
The activation ofthepulse generatorisindependent oftheA. VERMEULEN
gonads asitoccurs atthe sameageinagonadalindividuals
as in normal adolescents.
Restraint ofthe onset ofpuberty resides in the central
nervous system (1). In industrialized countries, the age of
puberty has decreased steadily over the last century in
association with the improved socioeconomic status, and
this suggests that nutritional status has an influence on
the maturation ofthe pulse generator. Before the central
nervous system (CNS) activates puberty, a certain level of
neural maturity must be reached, and it is known that
bone ageis abetterreflectionofmaturitythanchronologi-
cal age. A critical body mass is also required before the
CNS starts to activatepuberty(4). Underweightboys and
girls and adolescents with apoornutritional status have a
delayed puberty. Chronic stress also causes maintenance
of the prepubertal hypogonadotropic status, thereby
delayingpuberty, and such stress maybe mental, asin the
emotional deprivation syndrome, or organic, as in chronic
disease.
Adult Reproductive Function
The reproductive function in adults is dependent on the
intermittent discharge ofgonadotropins under the influ-
ence of pulsatile GnRH secretion by the GnRH pulse
generator, which functions as an integrator of neural,
hormonal, and metabolic signals and governs gonadal
functionbythe secretion ofgonadotropins. Thehypothala-
mo-pituitary-gonadal systemisthereforeextremelysensi-
tivenotonlytohormonalandmetabolicinfluences,butalso
to all factors affecting the central nervous system.
Androgens have an inhibitory effect at the hypothalamic
level and estrogens have their inhibitory effect at the
pituitary level, both resulting in reduced gonadotropin
secretion. Anabolic steroids, as used by some athletes and
body builders, and estrogens in food ingested in large
quantities also have similar inhibitory effects.
The endogenous opioid systemplays apivotalroleinthe
modulation ofthe GnRH pulse generator. Opioids have a
restraining effect, decreasing both leutinizing hormone
(LH) pulse frequency and amplitude (5,6). Exogenous
opioids such as morphine, methadone, and heroin have a
similar inhibitory effect causing decreased LH pulse fre-
quency and testosterone levels. Drug addicts frequently
have low plasma levels of sex hormones, leading to hypo-
gonadism, amenorrhea, and infertility.
The role of the adrenergic system in the regulation of
the GnRHpulsegeneratorinmanhas notbeencompletely
elucidated. It appears to stimulate the pulse generator in
nonhuman primates (7), but no convincing effects have
been detected in humans.
Amongtheperipheralfactorsaffectingthereproductive
system, stress plays animportantrole, whethermental or
physical. Mild stress (chair restraint) in nonhuman pri-
mates arrests the GnRH pulse generator (8), an effect
mediated by the corticotropin-releasing factor (CRF)
(9,10). CRF infusion in humans causes an inhibition of
pulsatile LH release (11). Fever is a common stressful
situation and is accompanied by an increased release of
CRF, which stimulates adrenal corticotropin hormone
(ACTH) secretion, resulting in increased plasma cortisol
levels, which inhibits pulsatile LH release. Fever-induced
CRF release appears to be triggered by cytokines,
especiallyinterleukin 1,which is animportantmediator of
activated macrophagefunction. Macrophages also release
vasopressin, which contributes to ACTH discharge but
may also play arole in the inhibition ofLH secretion. Itis
not surprising, therefore, that acute stress causes a rapid
decline inplasmatestosterone levels.Any acute infectious
disease induces a decrease in LH and testosterone levels
and is followed by a transient oligospermia.
Whereas the acute effects of stress on the pituitary-
gonadal axis appear to be mediated by CRF itself, in
chronic stress cortisol appears also to play a role in
decreasingplasma LHand testosterone levels. Theinhibi-
tory effects ofCRF on the GnRH pulse generator appear
to be mediated by the opioid system because they are
neutralizedbythe anti-opioid Naloxone. Emotional stress,
including endogenous depression, in women may be the
cause ofpsychologic hypothalamic amenorrhea,which ap-
pearstobesecondarytoimpairedpulsatileGnRHrelease.
In this condition there are low basal LH levels and de-
creased LH pulsatility, but a normal response to GnRH,
which indicates functional integrity ofthe adenohypophy-
sis and therefore a hypothalamic origin ofthe hypogonado-
tropism. There is evidence that increased hypothalamic
,B-endorphin plays animportantrole in the stress-induced
inhibition of gonadotropin secretion (12). The emotional
stress ofextended school examinations may also induce a
decrease in testosterone levels onboys and amenorrheain
girls (13).
Physical stress such as competitive sports causes a
reductioninthe LHpulsefrequency,leadingtolowtestos-
terone levels in men and amenorrhea in women (14). Cum-
mingetal. (15)observedthatrunningforexercisecauseda
reduction in LH pulse frequency without any change in
pulse amplitude. Elias et al. (16) detected a decline in LH
levels followingexercise onthetreadmill, reachinganadir
at90min, andthiswasassociatedwith anincreaseinCRF
levels, which was proposed to be the mediator ofthe LH
changes.Theredoes notappeartobeanydifferencein LH
level and LH pulsatility, either under basal conditions or
after Naltrexone administration, after a 10-15 mile run in
men trained for endurance running in comparison to
sedentary controls (17).
The effects of physical trauma are exemplified by the
decline in testosterone levels during surgery (18),which is
proportional bothin degreeandindurationtothe severity
of the surgical procedure. Following major surgery,
depressed testosterone output persists for 3 weeks. The
influence of chronic physical stress, such as industrial
noise or altered daily rhythms caused by night work or
shiftwork, onreproduction shouldbeconsidered, butthere
are no control data available.
Acute orchronicfoodrestrictionhasaninhibitoryeffect
on pulsatile GnRH release. Chronic undernutrition may
arrest pubertal development, and it is associated with
gonadal atrophy and infertility in adult men (19) and with
irregular menstrual cycles or amenorrhea in women (20).
Cameron et al. (21) showed that 1 day offasting in rhesus
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monkeys caused minimal weight loss but significant
decrease in LH and testosterone pulse frequency. In men,
a 48-hr fast caused a significant decrease in mean plasma
LH and testosterone pulse frequency but an unchanged
pulse amplitude (22). Komaki et al. (23) reported a slight
increaseinplasma f-endorphinlevelsduringacutefasting
but this was not maintained during prolonged fasting.
A complex interplay of fasting, malnutrition, and neu-
ropsychiatric factors are responsible for the amenorrhea
ofpatient with anorexia nervosa. Gonadotropin levels are
low and LH pulse frequency is decreased. The responses
to GnRH revert to those seen in prepubertal children.
However, the normal, adult-type responses are restored
by chronic treatment with pulsatile GnRH orweight gain
(24,25).
Exogenous obesity appears to have more subtle effects
onreproductive function. Male obesityis associatedwith a
decrease in plasma levels ofboth total and free testoster-
one, thedecreaseinfreetestosteronebeinglessimportant
becauseofaconcomitantdecreaseinsex-hormone-binding
globulin (SHBG) capacity. Changes in SHBG capacity are
probably caused by a direct effect of hyperinsulinism on
hepatic SHBG synthesis. The mechanism forthe decrease
in testosterone levels is not apparent. The LH pulse fre-
quencyisnormalinobesemen;however, thereis areduced
frequencyoflargeamplitudepulses, andtheamountofLH
secreted at each pulse is less than in nonobese men.
Female obesityis frequently associatedwith menstrual
irregularity and amenorrhea. Testosterone levels,
especially free testosterone, are increased, and the bind-
ing capacity of SHBG is reduced, probably as a conse-
quence ofincreased insulin and IGF-1 levels.Ashort-term
low caloric diet of 400 kcaVday for 4 weeks will usually
normalize the androgen levels with resumption ofovarian
cyclical activity, although, notwithstanding weight loss,
the obesity itselfpersists.
The effects of type of diet on the reproductive system
have been examined. We could not detect any difference is
plasma total or free testosterone levels between men on a
normal Western diet and men consuming a macrobiotic
vegetarian diet (26). Key and co-workers (27) observed
thatincomparisontoomnivores,vegetarianshad substan-
tially higher SHBG levels, but total and free testosterone
levels andestradiol (E2)levelswere similar. Belanger etal.
(28) found higher SHBG levels in vegetarians, although
testosterone levels were normal. Adlercreutz et al. (29)
reported that women eating a Western diet had high sex
hormone and low SHBG levels, resulting in a high bio-
availability of the hormones compared to vegetarian
women. Similarresultswere observedbyArmstrong etal.
(30) in postmenopausal women. There appears to be a
positive correlation between dietary fiber intake and
SHBGlevels so that ahigh fiberintakewould resultin low
levels ofbioactive sex hormone (29,31,32), although Key et
al. (27) could not confirm this finding (27). Surprisingly
Meikle et al. (33) reported that a fatty meal reduced the
levels oftotal and free testosterone, whereas Bennett and
Ingram (34), on the contrary, observed an inverse correla-
tion between fat intake and SHBG levels in postmeno-
pausal women.
Caucasian men have higher testosterone and E2 levels
thanJapanesemen,butitisnotcertainifthedifferencesin
sex hormone levels are due to differences in diet (35).
Similarly, Chinese men and women have much lower
androstanediol glucuronide levels than their Caucasian
counterparts (36), whereas postmenopausal American
women have significantly higher estrogen levels than Jap-
anesewomen(37). Itisnotclearwhetherdietaryorgenetic
factors are responsible for these differences. The racial
variability in sex hormone levels may be important for
explaining the differences in prevalence ofdifferent types
ofcarcinoma, ormaybethereasonforthedifferenteffects
produced by hormonal male contraception.
Malesmokershavehigherlevelsoftotalandfreetestos-
terone than nonsmokers (26). Some reports (38,39) indi-
cate that smoking does not have a significant effect on
spermatogenesis or sperm quality. However, Spira et al.
(40), studying the sperm characteristics of409 men being
investigated for infertility and 311 men requesting vasec-
tomy, observed that sperm density, motility, and morphol-
ogy were lower among fertile smokers than fertile
nonsmokers, and the semen ofinfertile smokers contained
lower numbers of spermatozoa with normal morphology.
The alterations ofspermcharacteristicswereunrelated to
the quantity oftobacco smoked or inhaled.
Smoking has been reported to be accompanied by
slightly increased E2 and progesterone levels during the
follicular phase of premenopausal women and in
postmenopausal women, and this was attributed to stim-
ulation ofthe adrenal cortex (41). Estradiol metabolism in
smokers is shifted toward the inactive 2-hydroxylated
catechol metabolites instead of toward 16-hydroxylated
metabolites (42).Thenewbornbabies ofwomenwhosmoke
heavily have a significantly lower weight than those of
nonsmokers.
Acutealcoholintoxicationfollowing1.5galcohoVkgbody
weight decreases plasma testosterone levels in men by
about 25% between 10-16 hr after the start of drinking,
although SHBG levels are unchanged, and LH pulsatility
and biological activity are unaffected. This suggests a
direct effect on the testis (43,44), but the absence of
enhanced LH secretion in response to low testosterone
suggests an inappropriate pituitary response in addition
(45).
Chronic alcoholics have reduced plasma testosterone
levels butusually stillwithinthe normal range (46,48), and
the reduction is directly correlated with the severity and
duration ofthe alcoholism and the eventual hepatic injury
(47). Testicular atrophy often accompanies alcoholic liver
cirrhosis (49). A multicenter World Health Organization
study of infertile couples that examined sperm charac-
teristics found that men with excessive alcohol consump-
tion had a higher prevalence ofazoospermia (9.6% versus
7.2%) and seminal abnormalities (52%versus36%),butthe
differences were not significant (50). Similar results were
found by Spira et al. (40).
Infections may have a direct effect on fertility, includ-
ing mumps, which causes orchitis and oophoritis in a
large proportion ofcases when occurring after puberty,
and this may produce infertility as a consequence. The
93A. VERMEULEN
human immunodeficiency virus (HIV) may also cause
infertility.
Age and Fertility
Age appearsto affectfecundityinbothmen andwomen.
It has recently been shown that women whose husbands
hadazoospermiaandwhohadreceivedartificialinsemina-
tion with donor semen (AID) had a significant decline in
fecundity after the age of 35 years (51-53). The rate of
spontaneous abortion also increases with maternal age
(53), probably due to an increased frequency ofchromoso-
mal abnormalities (54,55). The percentage offetuses with
chromosomal anomalies is double in women over 40 in
comparison towomenunder20. Prolonged follicularphase
or delayed fertilization in relation to reduced coital fre-
quency in older couples mayplay a role in the reduction of
fecundity (56,57). It therefore appears that the decline in
fertility with age may be due mainly to a diminishing
number of oocytes that are capable of forming normal
embryos (58).
Uterine factors mayalso have an effect on the declining
fertilitywith age. However, the age-associated increasein
trisomyis detected earlierthan the age-associated effects
on uterine function, and it can therefore be concluded that
the effects of aging on the quality ofthe ova appear at a
younger age than the effects of age on uterine function.
Decreasing fertility with age is also associated with an
increased frequency of endometriosis, fibroids, or tubal
pathology as a result ofpelvic infections.
Male fertilityhas an almost linear decline after the age
of40, according to Anderson et al. (59). However, Mineau
and Thussel (60) claim adecline infertility fromthe age of
25. The increasing prevalence of epididymitis, ductal
obstruction, and chronic prostatitis may contribute to the
decline in male fertility with age.
Factors Altering the Age ofMenopause
Menopausesignifiestheirreversibleendofreproductive
life in women and is a consequence of the progressive
depletion of ovarian follicles. The primary origin of the
menopause in the ovary inwomen is in clear distinction to
the situation in some laboratory animals such as the rat in
which the cessation of estrous cycles has a hypothalamic
origin. Transplantation ofovaries from old ratsintoyoung
rats may result in a resurrection ofcyclical activity.
The premenopausal period has avariable duration of1-
10yearsandischaracterizedbyaprogressivelengthening
of the menstrual cycle in contrast to the tendency of
progressive shorteningwith age prior to this period. The
progressive depletion of follicles makes the ovary rela-
tivelyresistant to gonadotropins, which is reflected in the
relativelyhighfollicle-stimulatinghormone (FSH)levelsin
the presence ofrelatively low E2 levels. There is frequent
anovulator,v dysfunctionaluterinebleeding. Estradiollev-
els only occasionally and at irregular intervals reach the
threshold capable ofinducing an ovulatory LH peak, and
this is followed by a luteal phase, which is often short or
inadequate. Atbirth, about 3,000,000 oocytes are present,
but this falls tojust over 300,000 at puberty and very few
are present at the menopause.
Menopause in Western countries generally occurs
betweentheagesof46and58(mean: 51.5years),andthere
is asmall seculartrendtoward an olderage atmenopause.
Environmental factors that may affect the age at meno-
pausehavebeenexamined in afewstudies.Van Keep et al.
(61) suggest that a) housewives and agricultural workers
have their menopause approximately 1 year later than
manualworkers orotheroccupationalcategories. b) Single
women have an earliermenopause than marriedwomen. c)
Smoking advances the age ofmenopause by a mean of1.5
years, confirmingprevious data (62-64). d) Parity and age
at last pregnancy is positively correlated with a later
menopause. e) Weight adjusted for height (body mass
index) does not influence the age at menopause, although
other authors have reported a later menopause in obese
women (65) or menstrual irregularities occurring 4-5
yearsearlierinthepremenstrualperiodinobesewomen.J)
Undernutrition may induce an early menopause. Data
from sub-Saharan Africa or the Punjab suggest a mean
age at menopause in the early 40s, but other authors (67)
cast doubt on the effect ofnutritional status on the rate at
which the ovary is depleted of oocytes. However, nutri-
tional status may determine when the last menstrual
period occurs (nutritional amenorrhea and premature
ovarian failure). g) Early menarche appears to be associ-
ated with late menopause and vice versa. h) Altitude-
associated hypoxia may cause early menopause as indi-
cated by data from the altiplano ofPeru, where the age of
menopause is advanced byjust over 3 years (68).
Recently, the role ofsome ofthesefactors as codetermi-
nants of age at menopause was challenged by Brambilla
andMcKinlay(66)whoconcludedfrommultivariate analy-
ses thatmarried status, parity,weight, education, income,
and use of oral contraception did not influence the age at
menopause, and the only relevant factor was smoking,
which was associated with a significantly earlier meno-
pause. It should be stressed that the influence ofall ofthe
abovefactorsislimited, andeach oneproduces atthemost
a difference of1-2 years in mean age at menopause.
Subjects with mosaic forms of Turner's syndrome or
womenwith short-arm deletion ofoneX-chromosomemay
be fertile, but usually have a premature menopause.
Mumps oophoritis may also cause premature menopause
(69). However, the most frequent cause of premature
menopause is total hysterectomy and oophorectomy. In
Western Europe, 10-15% of women aged 50 have under-
gone ahysterectomy(70),whereasinPittsburgh, Pennsyl-
vania, 24%whites and 47% ofblacks aged 40-50 have had
this operation (71). Unfortunately, no data are available on
the frequency of concomitant oophorectomy.
Premature menopauseimplies depletion ofovarianfolli-
cles as a consequence ofaccelerated atresia or decreased
germ cell number and is therefore irreversible. On the
otherhand,prematureovarianfailureinitsstrictestsense
is characterized by a resistant ovary with the continued
presence ofimmature follicles in association with elevated
peripheral gonadotropin levels. This may be an idiopathic
disorder of unknown etiology or may be associated with
94ENVIRONMENTAND HUMAN REPRODUCTION
autoimmune disorders, among which the most frequent
are thyroiditis and autoimmune Addison's disease. Cir-
culating antibodies to ovarian tissue are frequently
detected, and antibodies to FSH receptors may also be
found occasionally. Autoimmune premature ovarian
failure may also be part ofa polyglandular failure includ-
ing hypoparathyroidism, hypoadrenocorticalism, and
mucocutaneous conditions.
Irradiation and chemotherapy, especially with alkylat-
ing agents, frequently cause premature ovarian failure.
Autoimmune, postirradiation, and postchemotherapy
ovarian failure allmaybereversible, thusprovingthatthe
ovarywasnotcompletelydepletedoffollicles. Thesecondi-
tions, therefore, must be differentiated from true meno-
pause.
The age atmenopause mayberelatedtolongevity. Inan
epidemiological study, 5287white Adventists aged 55-100
yearswho had reachedmenopause naturallywereinvesti-
gated (72), and the age-adjusted death rate over a 6-year
period calculated. The ratio of the death rate for women
who reached a natural menopause before the age of 40
compared to the death rate forwomen reporting anatural
menopause at age 50-54 years was 1.95 (95% confidence
limits 1.24-3.07).
The Postmenopausal Era
The postmenopausal years are characterized by
extremelylowlevelsofestrogens. Inthefirst3yearsafter
the menopause the ovary still contributes to the estrogen
levelswhich are, however, lowerthanin the earlyfollicular
phase before the menopause. In later menopause, more
than 4 years after cessation ofmenses, the estrogens are
synthesized almost exclusively in peripheral tissue,
especially fatand muscle, from androgens secretedbythe
adrenals (73). A rare exception is thecal hyperplasia in
which the ovary produces an excess ofestrogen. Adrenal
androgen secretion decreases progressively with age, the
levels of dehydroepiandrosterone at the age of 75 years
being only one-fifth the levels at 20 years.
The estrogens produced by peripheral conversion of
androgens,althoughpresentatalowlevel, dohaveaphysi-
ological role in that they reduce pathological postmeno-
pausal osteoporosis.
Cigarette smokers have significantly higher levels of
androstenedione than nonsmokers (42), also during early
menopause (75). Smoking causes a shift of estrogen
metabolism toward inactive metabolites and a consequent
reduction in estrogen levels which increases the risk of
osteoporosis and pathological fractures (76). Estrone and
estradiol levels tend to decline with increasing alcohol
consumption.
Physicallyactivewomenhavelowerestrogenlevelsthan
physically inactive women, but surprisingly there is a
positive correlation between muscle strength and
estrogen level (74). Obese women have higher estrogen
levels as aresultofincreased conversion ofandrogensinto
estrogens in fat tissue and consequently have a lower
frequency of osteoporosis. Osteoporosis is much more
frequent in thinner women and in women receiving
glucocorticoids, which not only have a catabolic effect but
also depress the secretion of adrenal precursors of
estrogens. Chronic stress and depressive states in
postmenopausal women are accompanied by low andro-
stenedione and estrogen levels and excretion (77).
Andropause
Middle age in males, in contrast to females, is not
characterized by a sudden discontinuity in fertility
although fertility declines progressively from the age of
25-40 onwards (53,59,60). It is now generally accepted
that Leydig cell function declines in elderly men. Almost
all authors report a significant age-associated decrease in
free testosterone levels, although in exceptional cases
healthy elderly men maintain unchanged levels of total
testosterone. Primarytesticular factors undoubtedly play
amajorroleintheage-dependentdeclineinplasmatestos-
terone levels and this is associated with a decreased
number ofLeydig cells (78), impaired testicular perfusion
(79),impairedsteroidsynthesis(80), anddecreasedtestos-
terone output in response to hCG stimulation (81,82). A
similar diminished response to increased biologically
active LH levels occur after clomiphene administration
(83). The moderate but significant increase of LH levels
with ageisconsistentwithprimarytesticulardeficiencyin
the elderly.
In addition to primarytesticular failure in elderlymen,
there are also alterations of the hypothalamo-pituitary
pole ofthe hypothalamo-gonadal axis as evidenced by a)
failure tomaintain normal free testosterone levels in spite
of adequate secretory reserve ofboth gonadotrophs and
Leydigcells, b) disappearance ofnychthemeral variations
in testosterone levels (84), c) decreased frequency oflarge
amplitude LHpulses(85),d)decreased orabsentresponse
ofLHlevelstoantiopioids oranti-estrogens (86,87), ande)
increased sensitivity ofthe gonadotrophs to sex hormone
feedback (85,88).
The aging process has less of an influence on sper-
matogenesis. Alterations in sperm quality in old age are
minimal and characterized essentially by a decrease in
motilityandnumberofspermatozoawithnormalmorphol-
ogy (72,73). However, there is a significant decrease in
daily sperm production in elderly men (90). Plasma FSH
levels increase with age, probably in relation to a de-
creased inhibin secretion, which is a consequence of the
age-associated impairment ofSertoli cell function in addi-
tion to the decrease in the number ofSertoli cells in men
50-80 years old (91).Although there is clearevidence for a
decreaseinfertilityinelderlymen(59,60,92)thezona-free
hamster egg fertilizing ability of spermatozoa from
healthy elderly men appears to be similar to that ofyoung
men (89,92).
Leydig cell function is more resistant to environmental
factors than Sertoli cells, and there is no clinical hallmark
ofSertolicellfunctioninelderlymen,who aregenerallyno
longerinterestedinfertility. Itisnotsurprising,therefore,
that few data are available on factors that accelerate the
decline in testicular function with age. However, this
decline is dramatically accelerated by acute or chronic
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diseaseasaconsequenceoftransienthypogonadotropism,
although direct effects at the testicular level may also play
arole (93). Plasmatestosteronelevels decreasemuchmore
rapidlywithagein subjectswhohave even aminorchronic
affliction than in perfectly healthy men.
Depression is associated with a decrease in both LH
and testosterone levels, probably mediated by CRF, the
levels of which are increased in many cases. Systemic
diseases such as granulomatous leprosy may damage the
testes directly, whereas hemosiderosis has an indirect
effect, acting by way of impairment of hypothalamo-
pituitary function. Other diseases may alter hormone
release or metabolism atmultiple sites in the hypothalmo-
pituitary gonadal axis as occurs in renal failure, which is
associatedwithincreasedprolactinlevels, decreasedpitui-
tary response to GnRH, and decreased testicular
response to hCG. In chronic pulmonary flbrosis, there is
significant correlation between plasma testosterone levels
and arterial oxygen tension (PaO2). Testosterone levels
become subnormal when PaO2 drops below 55 mm Hg
because hypoxia suppresses the hypothalamo-pituitary
axis (94). Uncorrected varicocele causes a more rapid
decline in Leydig and Sertoli cell function with age in
comparison to normal controls (96).
There is clear evidence that aging is associated with a
decreased ability to maintain homeostatic functions and
associated with a decreased responsiveness to stress. It
must be asked, therefore, ifchronic stress accelerates the
neurodegenerative aspects ofaging. Considerable experi-
mental evidence in animals suggests that chronic stress
accelerates hippocampal neuronal death due to excessive
exposure to glucocorticoid (95). However, only very little
information is available in men, and this is hardly surpris-
ing considering the absence of a universally accepted
deflnition of stress. Several papers have suggested that
there has been a decline in sperm quality and fertility in
the general population over the last few decades, which
may be due to the combined effects ofincreasing popula-
tion, exposure to radiation, and population stress (91,97-
101).
Toxic Effects ofDrugs or Chemicals on
Gonadal Function
Thereisalargelistofvarioussubstancesthathavebeen
reported to have an adverse effect on gonadal function,
and it will not be possible to discuss each one at length.
Only some ofthe most important substances will be men-
tioned, and drugs affecting potency, such as anti-
dopaminergics, will not be discussed.
Centrally Acting Drugs. The effects ofmorphine and
its analogues on the pulse generator have already been
discussed. All heroin addicts, and 45% of methadone
addicts, have decreased spermatozoa motility, and 25%
also have teratospermia (102).
Somecocaineabusershavehigherthannormalprolactin
levels,butnosignificantdifferencesineitherLH ortestos-
teronepulsefrequency(103). Cannabinoids arereportedto
depress Leydig cell function (104).
Heavy Metals. Lead intoxication sufficient to cause
clinical poisoning (blood lead levels of 66-139 Rg/dL)
appears to induce oligo- and azoospermia in asubstantial
proportion of exposed individuals (105). Cadmium is
known to damage testicular blood vessels, causing isch-
emia andtubularnecrosis. Chronic exposure to thalliumis
less toxic because it is taken up bymetallothionein, which
is formed in the testis (106).
Nitrogen, Sulfur, or Phosphorus-Containing Com-
pounds. Nitrofurans inhibit spermatogenesis (107).
Chronic exposure to carbon disulfide, used in the viscose
industry, causes an increase in gonadotropin levels among
workers exposed for an average of 15 years to an atmo-
spheric level of 120-240 mg/m3 (108). Organophosphates
(parathione) cause infertility in farm animals, inhibit tes-
tosterone metabolism in rodents, but have no apparent
effects on Leydig cell function in man (109).
Hormones. Aminoglutethimide, spironolactone, ket-
oconazol, metyrapone, ortho-para-DDD, and cimetidine
all have a direct effect on sex hormone activity.
Anabolic steroids, abused by body builders, block pitui-
tary gonadotropin release leading to a hypogonadotropic
state and low intratesticular androgen concentrations. It
is not surprising, therefore, that oligozoospermia is a
frequent finding in body builders abusing anabolic
steroids. However, this inhibition of spermatogenesis is
reversible even after prolonged use of very large doses
(110).
Progestational drugs such as megestrolacetate, me-
droxyprogesterone acetate, and cyproterone acetateblock
gonadotropin secretion and therefore block Leydig cell
function and spermatogenesis. They also have some anti-
androgenic activity.
Pure antiandrogens such as flutamide or anandron
activate the secretion ofgonadotropin and sex hormones.
The effects at the cellular levels of sex hormones are
blockedbythecompetitivebindingofantiandrogens tothe
androgen receptors.
Anti-estrogens such as chlomiphene or tamoxifen also
activate gonadotropin secretion andmaybeused to induce
ovulation or induce spermatogenesis. Oral contraceptives
prevent conception by blocking ovulation and/or by caus-
ing changes in cervical mucus characteristics that retard
sperm penetration and by hindering implantation of the
zygote.
Pesticides. Several reports have mentioned infertility
associated with oligo- and azoospermia amongst workers
exposed to kepone pesticides such as dibromochloropro-
pane(DBCP) (111). DBCP(anematocide) and2,3-dibromo-
propanol induce oligo- or even azoospermia in factory
employees (112), which appears to be partially reversible
when exposure ceases if FSH levels have remained nor-
mal. Polychlorinated biphenyls (PCB), polychlorinated
dibenzdioxins (PCDD), and dibenzfurans (DBF)have sim-
ilar effects.
Cytostatics and Antimetabolites. ALKYLATING
AGENTS. Chlorambucil (Leukeran), Melphalan (Alkeran),
cyclophosphamide, Ifosfamide and nitrosourea derivates
(BCNU, CCNU),andimidazocarboxamides (dacarbazine)
are known to induce germinal aplasia in men, whereas
96ENVIRONMENT AND HUMAN REPRODUCTION 97
Leydigcellfunctionisgenerallypreserved oronlyslightly
impaired. The onset of the testicular toxic effect is dose
dependent, and apartial recoveryofspermatogenesis may
be expected on cessation of therapy with even the pos-
sibility of paternity. These alkylating agents in women
have atoxic effect ontheprimaryfollicles and oocytes and
induce amenorrhea. The age at treatment is an important
determinant: younger women resume ovulatory activity
more frequently than women over 40 years of age. As a
rule, ovaries are more resistant to chemotherapy-induced
damage than testes. Treatment with alkylating drugs
beforepubertyorinadolescence does notaffectfertilityin
women, whereas only a small proportion of men who
survive appear to retain fertility. Nevertheless, the testes
of prepubertal boys are relatively more resistant to
alkylating agents than adult testes.
ANTIMETABOLITES. The antimetabolites such as folic
acid antagonists (methotrexate), purine analogues (mer-
captopurine, azothioprine) and pyrimidine analogues (flu-
orouracil, cytarabine) cause less severe effects on
spermatogenesis, and onlywhen used at higher doses.
CYTOsTATIc ACTIVE ANTIBIOTIcs. Actinomycin, daun-
orubicin, doxorubicin, epirubicin, bleomycin vinca
alkaloids (vincristine, vinblastine) and etoposide have less
toxic effects on the gonads. Combination chemotherapy
using cytostatic regimes that include alkylating agents or
procarbazine frequently produce irreversible azoosper-
mia, whereas combinations not containing these drugs
produce germ cell aplasia less frequently and the depres-
sive effects are generally transient (113). Attempts to
prevent the toxic effects on the testis by using GnRH
analoguesinordertoinhibitspermatogenesis haveproved
ineffective.
RADIATION. Theeffectsofradiation onspermatogenesis
(transient orpermanentazoospermia) depend onthetotal
dosereceivedandonwhetherthedoseisfractionated(114).
The ovary is less sensitive to irradiation than the testis.
Theyoungerthewoman, thelessthe chance ofpermanent
sterility. This age difference is related to the number of
oocytes remaining in the ovary. Children of parents
exposed toeitherradiation orchemotherapydo notappear
to have an increased incidence of chromosomal abnor-
malities or congenital anomalies.
Conclusion
Thehypothalamo-pituitary-gonadal axisisregulatedby
a complex interplay of neural, hormonal, and metabolic
signals, andnotsurprisingly,therefore,maybeaffectedby
many environmental factors. Stress ofany form, acute or
chronic disease, nutrition, obesity, alcohol, smoking, and
drugs ofaddiction all affect reproductive function, More-
over, alarge number ofpharmaceutical agents, alkylating
agents, industrial toxins, and pesticides, in addition to
irradiation, induce infertility, which is not infrequently
irreversible.
Fertility decreases significantly with age in both men
and women, and chromosomal abnormalities play an
importantpartinthisdecline.Age atmenopauseislargely
determined by genetic factors, and environmental factors
play a minor role. Premature ovarian failure with per-
sistentimmature follicles is asecondaryphenomenongen-
erally related to autoimmune diseases.
Ofgreatconcernisthe suggestive evidence ofdecline in
sperm quality over the last decades. Ifthis is confirmed,
preservation of the human race may necessitate strict
measures to reduce pollution drastically and to control
irradiation and other noxious agents which impair sper-
matogenesis.
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